• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    The present invention relates to a process for enriching a biomass of microalgae of the genus Thraustochytrium with DHA and amino acids arginine and glutamic acid, characterized in that it comprises a step aimed at limiting the growth rate of the microalgae. while maintaining or continuously introducing a source of nitrogen into the fermentation medium.
    公开号:FR3031984A1
    申请号:FR1550598
    申请日:2015-01-27
    公开日:2016-07-29
    发明作者:Bernard Caulier
    申请人:Roquette Freres SA；
    IPC主号:
    专利说明:

    [0001] The present invention relates to a novel fermentative process for enriching the biomass of microalgae of the genus Thraustochytrium, more particularly Schizochytrium sp or Schizochytrium. mangrovei, docosahexaenoic acid (or DHA) and amino acids arginine and glutamic acid, and a process for producing the oil extracted from this biomass of microalgae.
    [0002] The technical field of lipids Lipids are one of the three major families of macronutrients with proteins and carbohydrates. Among the lipids, there are especially triglycerides and phospholipids: - Triglycerides (also called triacylglycerols or triacylglycerides or TAG) are glycerides in which the three hydroxyl groups of glycerol are esterified with fatty acids. They are the main constituent of vegetable oil and animal fats. Triglycerides account for approximately 95% of dietary lipids ingested by humans. In the body, they are present mainly in adipose tissue and constitute the main form of energy storage. Phospholipids are amphiphilic lipids, that is to say consisting of a polar "head" (hydrophilic) and two "tails" aliphatic (hydrophobic). Phospholipids are lipids of structure because they are constituents of the cellular membranes of which they ensure among others the fluidity. Triglycerides and phospholipids are composed mainly of fatty acids that are both provided by the diet and, for some of them, synthesized by the body. The biochemical classification (based on the number of double bonds contained in the fatty acid molecule) distinguishes between saturated fatty acids (AGS), monounsaturated fatty acids (MUFA) and polyunsaturated fatty acids (PUFAs). From a physiological point of view, we distinguish: - the essential fatty acids necessary for the development and the good functioning of the human body, but which our body does not know how to manufacture; the so-called "conditionally" fatty acids that are essential, essential for the normal growth and the physiological functions of the cells, but which can be made from their precursor if it is supplied by the diet. They are therefore strictly required if their indispensable precursor is absent. - non-essential fatty acids. The essential and "conditionally" essential fatty acids are the essential fatty acids. Other fatty acids are called non-essential. Non-essential fatty acids include: - eicosapentaenoic acid (EPA) of the omega 3 fatty acid family, - oleic acid, the predominant monounsaturated fatty acid in our diet, and palmitoleic acid. saturated fatty acids, such as lauric acid, myristic acid or palmitic acid. More particularly, the polyunsaturated fatty acids are classified according to the position of the first double bond, from the final methyl function.
    [0003] Thus, in the nomenclature, for omega "x" or "nx", "x" corresponds to the position of the first unsaturation. There are two main families of essential fatty acids: omega-6 fatty acids (or n-6 PUFAs), whose precursor and major representative is linoleic acid (LA) and omega-3 fatty acids (or PUFAs). 3) whose precursor is alpha-linolenic acid (ALA). The majority of polyunsaturated fatty acids of biological interest belongs to the family of omega 6 (arachidonic acid or ARA) or omega 3 (eicosapentaenoic acid or EPA, docosahexaenoic acid or DHA). In addition, in the nomenclature, the number of carbon constituting the chain is also defined; thus EPA is described as C20: 5 and DHA as C22: 6. The "5" and "6" thus correspond to the number of unsaturations of the carbon chain presented respectively by the EPA and the DHA. DHA, from the family of omega 3 fatty acids, is a fatty acid that the body can synthesize from alpha-linolenic acid, or that is provided by the consumption of oily fish (tuna, salmon, herring). ..). DHA plays an important role in the structure of membranes and in the development and functioning of the brain and retina. Fish oils are mainly used as a source of omega 3 fatty acids, such as DHA and EPA, but they are also found in microalgae oils from which they are extracted either as a mixture or separately. as is the case for example oils from certain selected strains, such as those of the genus Schizochytrium, which contain only traces of EPA but high levels of DHA. The technical field of peptides and amino acids Peptides and amino acids are classically valued as functional agents or dietary supplements in many fields. In the context of the amino acid supply of interest, it may indeed be advantageous to have sources of peptides rich in arginine and glutamic acid.
    [0004] Arginine is an amino acid that has many functions in the animal kingdom. Arginine can be degraded and thus serve as a source of energy, carbon and nitrogen to the cell that assimilates it. In various animals, including mammals, arginine is decomposed to ornithine and urea. The latter is a nitrogen molecule that can be eliminated (by excretion in the urine) so as to regulate the amount of nitrogen compounds present in the cells of animal organisms. Arginine allows the synthesis of nitric oxide (NO) by NO synthase, thus mediating the vasodilatation of the arteries, which reduces the rigidity of the blood vessels, increases the blood flow and thus improves the functioning of the blood vessels. Dietary supplements that contain arginine are recommended to promote heart health, vascular function, to prevent "platelet aggregation" (risk of blood clots) and to lower blood pressure. The involvement of arginine in wound healing is related to its role in the formation of proline, another important amino acid for collagen synthesis. Arginine is also a component frequently used, especially by athletes, in energy drinks.
    [0005] Glutamic acid, on the other hand, is not only one of the elementary building blocks used for protein synthesis, but is also the most common excitatory neurotransmitter in the central nervous system (brain + spinal cord) and is a precursor GABA in GABAergic neurons. Under the code of "E620", glutamate is used as a flavor enhancer for foods. It is added to food preparations to enhance their taste.
    [0006] In addition to glutamate, the Codex Alimentarius has also recognized as flavor enhancers its salts of sodium (E621), potassium (E622), calcium (E623), ammonium (E624) and magnesium (E625). Glutamate (or its salts) is often present in ready-made dishes (soups, 5 sauces, chips, ready meals). It is also commonly used in Asian cooking. It is currently frequently used in combination with aromas in appetizers (bacon taste, cheese taste). This enhances the taste of bacon, cheese, etc. It is rare to find an aperitif that does not contain any. It is also found in some drug capsules but not for its taste functions. Finally, it is the majority component of kitchen auxiliaries (cubic broths, sauces, sauces, etc.). Production of lipids, in particular of fatty acids, by microalgae The cultivation of microalgae of the genus Schizochytrium is conventionally carried out in fermentors (heterotrophic conditions: in the dark in the presence of a carbon source). It should be noted that the profitable exploitation of these microalgae generally requires the control of the fermentation conditions.
    [0007] To achieve this result, first fermentation processes to obtain high cell densities (HCD for High-Cell-Density) were thus much worked, so as to obtain maximum yields and productivities in lipids. The objective of these HCD cultures was to obtain the highest possible concentration of the desired lipids in the shortest time. However, it soon became apparent to those skilled in the art that, for example, microalgae must be subjected to a nutritional stress which limits their growth when they wish to produce large lipid reserves. It is therefore classically decoupling growth / production in fermentative processes. For example, to promote the accumulation of polyunsaturated fatty acids (here docosahexaenoic acid or DHA), the patent application WO 01/54510 recommends dissociating the cell growth and the production of polyunsaturated fatty acids. More particularly, there is claimed a process for the production of microbial lipids, comprising the steps of: (a) fermenting a medium comprising microorganisms, a carbon source and a limiting nutrient source and providing conditions for the production of microbial lipids 3031984 Sufficient to maintain a dissolved oxygen level of at least about 4% of the saturation in said fermentation medium to increase the biomass; (b) then providing sufficient conditions to maintain a dissolved oxygen level of approximately 1% or less of saturation in said fermentation medium and to provide sufficient conditions to allow said microorganisms to produce said lipids; (c) and collecting said microbial lipids, wherein at least about 15% of said microbial lipids are polyunsaturated lipids; and wherein a biomass density of at least about 100 g / l is obtained during the fermentation. In the microalga Schizochytrium sp strain ATCC 20888, it is thus more particularly carried out a first phase of growth in the presence of a carbon source and a nitrogen source but without limitation in oxygen, so as to promote the obtaining of a in a second phase, stop the supply of nitrogen and gradually slow down the supply of oxygen (management of the dissolved oxygen pressure or pO 2 by 10%, at 4%, then 0.5 (3 / 0), in order to stress the microalgae, slow down its growth and trigger the production of the fatty acids of interest.In the microalgae Crypthecodinium cohnii, the highest content of DHA is obtained at low glucose concentration (of the order of 5 g / 1), and thus at low growth rate (Jiang and Chen, 2000, Process Biochem., 35 (10), 1205-1209) .Therefore, in cases where the formation of the products is not correlated with high cell growth it is taught that i It is wise to control the rate of cell growth. In general, those skilled in the art choose to control the growth of microalgae by controlling the fermentation conditions (temperature, pH, etc.), or by the regulated supply of nutritional components of the fermentation medium (semi-continuous conditions called "Fed-batch"). If he chooses to control the growth of microalgae in heterotrophy by the supply of carbon sources, the skilled person generally chooses to adapt the carbon source (pure glucose, acetate, ethanol, etc.) to the microalgae (C cohnii, Euglena gracilis ...) depending on the metabolite produced (for example a polyunsaturated fatty acid type DHA). Temperature can also be a key parameter. For example, it has been reported that the synthesis of polyunsaturated fatty acids in certain species of microalgae, such as EPA by Chlorella minutissima, is favored at a lower temperature than that required for optimal growth of said microalgae.
    [0008] In order to optimize the production of triglycerides, those skilled in the art are also led to optimize the carbon flow towards the production of oil, by acting on the nutritional environment of the fermentation medium. It is thus known that the accumulation of oil occurs during a sufficient carbon supply, but under conditions of nitrogen deficiency. The C / N ratio is here decisive, and it is accepted that the best results are obtained by acting directly on the nitrogen content, the glucose content not being limiting. To optimize oil production, it is therefore essential for the person skilled in the art to control the carbon flow by diverting it towards the production of oil, to the detriment of the production of proteins; the carbon flux is redistributed and accumulates in lipid reserve substances when the microalgae are placed in nitrogen-deficient medium. Protein production by microalgae As is detailed above, to optimize the production of triglycerides, the skilled person is led to optimize the carbon flow towards the production of oil, by acting on the nutritional environment of the medium. fermentation. In a Chlorella-type microalgae study, it was noted that nitrogen deficiency affects cell growth, resulting in a decreased growth rate of 30% over the normal growth rate of the microalgae ( Xiong et al., Plant Physiology, 2010, 154, pp1001-1011). To explain this result, Xiong et al, in the article cited above, demonstrate indeed that, if one divides the biomass of Chlorella into its main components, in particular carbohydrates, lipids, proteins, DNA and RNA (representing 85% of its dry matter), the C / N ratio has no impact on the content of DNA, RNA and carbohydrates, but it becomes preeminent for the protein and lipid content. Thus, Chlorella cells cultured with a low C / N ratio contain 25.8% protein and 25.23% lipid, while a high C / N ratio allows 53.8% synthesis. of lipids and 10.5% of proteins. To optimize the production of proteins, it is therefore essential for the skilled person to control the carbon flow by deflecting it to the production of proteins to the detriment of lipid production; the carbon stream is redistributed and accumulates in protein reserve substances when the microalgae are placed in a non-nitrogen deficient medium.
    [0009] With this teaching, for the production of biomasses rich in proteins and therefore amino acids that constitute them, the skilled person is therefore brought to work the fermentation conditions by favoring rather a low C / N ratio, and thus : make a significant contribution of nitrogen source to the fermentation medium, while maintaining constant the carbon source feed which will be converted into proteins and stimulate the growth of the microalgae. SUMMARY OF THE INVENTION The present invention relates to a process for producing a biomass of microalgae of the genus Thraustochytrium whose lipid fraction is rich in DHA and whose amino acid content arginine and glutamic acid on total amino acids is high. .
    [0010] This method is based on the control of the growth rate of the microalgae, this control being carried out so as to reduce it to a minimum, while maintaining or continuously introducing a source of nitrogen into the fermentation medium. This result can for example be obtained by reducing or depleting trace elements of the fermentation medium or by limiting the transfer to 02.
    [0011] In a preferred embodiment of the process according to the invention, it is thus chosen to limit the growth rate of the microalgae by limiting the oxygen supply. For the purposes of the invention, the limitation of the growth rate is assessed by the ratio of the actual growth rate of the microalgae (p) with respect to its optimum growth rate (pmax), where "μ" is the growth rate expressed in g of biomass formed per g of biomass per hour, ie (h-1). More particularly, the process of the invention is a process for enriching a biomass of microalgae of the genus Thraustochytrium with DHA and with amino acids arginine and glutamic acid, characterized in that it comprises a step of maintaining or adding a source of nitrogen in the fermentation medium as soon as the value of the ratio of growth rates p / pmax microalgae becomes less than 0.2. Preferably, the microalgae are of the genus Schizochytrium sp or Schizochytrium mangrovei. More specifically, the microalgae may be a strain selected from strains CNCM 1-4469 and CNCM 1-4702 deposited at the National Collection of Microorganism Cultures of the Institut Pasteur respectively on April 14, 2011 and November 22, 2012.
    [0012] Optionally, the method may further comprise harvesting the biomass, optionally preparing an extract or cell lysate from this biomass, and optionally extracting a crude oil rich in DHA and arginine amino acids. and glutamic acid.
    [0013] The process according to the present invention can be characterized in that the biomass obtained comprises: at least 45% of DHA by weight of total fatty acids; and at least 10% arginine and at least 25% glutamic acid by weight over total amino acids, preferably at least 15% arginine and at least 40% glutamic acid by weight over total amino acids . DETAILED DESCRIPTION OF THE INVENTION Within the scope of the invention, the Applicant Company has chosen to explore an original route of optimization of the production of DHA and amino acids arginine and glutamic acid by proposing a new fermentation line. The applicant company has thus found, contrary to the technical prejudices in the field, that it is possible to produce by fermentation biomasses of microalgae: 20 rich in lipids (more than 25% by dry weight of biomass, preferably at least 30 (3/0) of which the predominant fatty acid is docosahexaenoic acid (DHA), and rich in amino acids arginine and glutamic acid (more than 35%, by weight of the total amino acids, preferably at least 55% minimum), without it being necessary, as described in the state of the art, to maximize the C / N ratio (carbon consumed on nitrogen consumed mole / mole). The lipid and amino acid composition of the fermented biomass can be modified by the unconventional maintenance for lipid production of the nitrogen supply throughout the fermentation even when the rate of fermentation is high. 1..14.1max growth is lower Indeed, the applicant company understood that when the ratio 1..14.1max becomes less than 0.2, following a limitation in a nutrient substrate other than nitrogen or carbon substrates, it is possible to divert metabolic productions towards the production of amino acids arginine and glutamic acid, while maintaining a significant production of DHA.
    [0014] In one embodiment, the limitation for decreasing the rate of growth may be the limitation of the oxygen supply (OTR, oxygen transfer rate). In particular, the OTR during the fermentation phase is preferably 30 to 35 mmol / L / h. The growth limitation can also be induced by depletion of trace elements or minerals, preferably selected from phosphate, magnesium or potassium.
    [0015] More particularly, the Applicant Company has found that it is necessary to provide a nitrogen supply, preferably in the form of ammonia (used for example in pH regulation), or that the nitrogen supply must be maintained until end of the crop, since the pt is less than 20% of max. In a preferred embodiment, the initial nitrogen supply is supplemented by the pH regulation, whereby the nitrogen consumed is compensated for by that of the pH regulation. This makes it possible to obtain a C / N ratio (carbon consumed over nitrogen consumed mole / mole) at the end of culture less than 20, for example between 10 and 15, and preferably about 15.
    [0016] Strains for use in the methods of the present invention are of the genus Thraustochytrium, more particularly Schizochytrium mangrovei or Schizochytrium sp. Such strains are known to those skilled in the art. The applicant company has identified during its research several strains of microalgae producing DHA of great interest. In particular, the applicant company is particularly interested in two strains that it has identified. The first strain is a strain of Schizochytrium sp., Deposited in France on April 14, 2011 at the National Collection of Cultures of Microorganisms of the Pasteur Institute (CNCM), 25 rue Docteur Roux, 75724 Paris Cedex 15, France, under 1-4469, but also in China at the Wuhan University CHINA CENTER FOR TYPE 30 CULTURE COLLECTION (CCTCC), Wuhan 430072, PR China under the number M 209118. This strain mainly produces DHA and to a lesser extent palmitic acid and palmitoleic acid. It was characterized by partial sequencing of the gene encoding the 18S RNA (SEQ ID No. 1): 35 1 GAGGGTTTTA CATTGCTCTC aTTCCaATAG CAaGACGCGA AGCGCCCCGC ATTGATATTT 61 CTCGTCACTA CCTCGTGGAG TCCACATTGG GTAATTTACG CGCCTGCTGC CTTCCTTGGA 121 TGTGGTAGCC GTCTCTCAGG CTCCCTCTCC GGAGTCGAGC CCTAACTCCC CGTCACCCGT 181 TATAGTCACC GTAGGCCAAT ACCCTACCGT CGACAACTGA TGGGGCAGAA ACTCAAACGA 241 TTCATCGCTC CGAAAAGCGA TCTGCTCAAT TATCATGACT CACCAAGAGA GTTGGCTTAG 3,031,984 10,301 ACCTAATAAG TGCGGCCCTC CCCGAAAGTC GGGCCCGTAC AGCACGTATT AATTCCAGAA 361 TTACTGCAGG TATCCGTATA AAGGAACTAC CGAAGGGATT ATAACTGATA TAATGAGCCG 421 TTCGCAGTTT CACAGTATAA TTCGCTTATA CTTACACATG CATGGCTTAG TCTTTGAGA allowing to identify it as a type strain Schizochytrium sp 5. This strain will be designated "CNCM 1-4469" later in this application. In addition, the second strain is a strain of Schizochytrium mangrovei. It produces DHA and palmitic acid in a relatively equal proportion. It was filed by the company Applicant in France on November 22, 2012 at the 10 National Collection of Cultures of Microorganisms of the Pasteur Institute (CNCM), 25 rue Docteur Roux, 75724 Paris Cedex 15, France, under number CNCM 1-4702. It has been characterized by sequencing the genes encoding the 18S rRNA (SEQ ID No. 2): ## STR2 ## CAGGGCTCTT TACCGAAGAA AACGCATACA ATTTACGCGC GTCGAGCCCT CAACTGATGG TCATGATTCA ACAGCATGTA ATTATTACTG CGCTTCGCAT CTGCTGCTAT AACTCTCCGT GGCAGAAACT CCAATAAAAT TTATTTCCAG ATATAATGAG CGATATTTCT CCTTGGATAT CACCCGTTAT CAAACGATTC CGGCTTCAAT AATTACTGCA CCGTTCGCAG 20,421 TCTCACAGTA CAATCGCTTA TACTTACACA GCAG allowing to identify it as a type strain Schizochytrium mangrovei. This strain will be designated "CNCM 1-4702" later in this application. Furthermore, the fermentative processes according to the present invention are carried out under heterotrophic culture conditions. These conditions adapted to the microalgae considered as well as the culture media are well known to those skilled in the art. The carbon source necessary for the growth of the microalga is preferably glucose.
    [0017] Preferably, the glucose supply is such that the glucose concentration during the fermentation is maintained at a concentration of 20 g / L or more. At the end of fermentation, the glucose concentration is at least 5 g / L. The nitrogen source may be yeast extracts, urea, sodium glutamate, ammonium sulfate, ammonia in pH regulation, alone or in combination. Generally, the culture step comprises a preculture step, to revive the strain, and then a culture or fermentation step itself. This last step corresponds to the production step of the lipids of interest, in particular DHA.
    [0018] Preferably, the pH is controlled during fermentation at a pH of between 5 and 7, preferably about 6. Preferably, the temperature during fermentation is 26-30 ° C, preferably about 28 ° C.
    [0019] The fermentation time is preferably at least 50 hours, preferably between 65 and 90 hours, even more preferably between 70 and 85 hours. The fermentation process according to the present invention allows (or is made so as to obtain) to obtain a biomass comprising at least 45% DHA by weight of total fatty acids. In addition, the method guarantees a lipid content by weight relative to the biomass of at least 25%. Thus, the biomass is well enriched in DHA. Furthermore, the fermentation process according to the present invention allows (or is carried out so as to obtain) to obtain a biomass comprising at least 40% of proteins by weight relative to the biomass. In addition, the proportion of glutamic acid relative to the total amino acids is at least 25%. The arginine content is at least 10%. For the strain CNCM 1-4702, the results obtained with the fermentation process according to the invention are a biomass comprising about 47% of DHA by weight of total fatty acids with a lipid content by weight relative to the biomass of 20%. about 35%, and about 53% protein with a proportion of glutamic acid of about 40% and arginine of about 16%. For the CNCM 1-4469 strain, the results obtained with the fermentation process according to the invention are a biomass comprising approximately 52% of DHA by weight of total fatty acids with a lipid content by weight relative to the biomass of 25%. about 26%, and about 43% protein with a proportion of about 26% glutamic acid and about 10% arginine. When reference is made to a percentage by weight, it is understood to mean dry weight.
    [0020] In addition to biomass, the present invention also relates to an extract or cell lysate prepared from this biomass. In particular, this extract or lysate is prepared from the biomass recovered after fermentation. This extract or lysate rich in DHA and amino acids arginine and glutamic acid. Cell disruption for the extraction of lipid content can be effected by various routes including mechanical, chemical, enzymatic pathways. Subsequently, an oil can be extracted from the cell lysate.
    [0021] Thus, the method for producing lipids of interest, preferably DHA, and amino acids arginine and glutamic acid, comprises the fermentative process according to the present invention, the harvesting of the biomass, the preparation of an extract or Cell lysate and crude oil extraction comprising the lipids of interest, preferably DHA, and optionally arginine and glutamic acid amino acids. By "about" is meant the value + or - 10% thereof, preferably + or 5% thereof.
    [0022] The invention will be better understood with the aid of the following examples, which are intended to be illustrative and nonlimiting. EXAMPLES Example 1 Crop Conditions of the CNCM 1-4702 Strain The protocol comprises a preculture for a fermentation of the fermenter with 0.1 g / L of biomass for the Schizochytrium mangrovei CNCM 1-4702 strain. Preculture The preculture (100 ml of medium) in 500 ml baffled erlenes lasts 24 hours at 28 ° C.
    [0023] All the components of the medium are sterilized by filtration. Table 1 Preculture Medium% (g / g) Glucose Anhydrous 3 Yeast Extract 0.4 Sodium Monosodium Sodium Glutamate 6.42 NaCl 1 1.25 MgSO 4 (H 2 O) 0.4 KCl 0.05 CaCl 2 2 (H 2 O 0.01 NaHCO3 0.05 KH2PO4 0.4 Vitamins stock solution B1, B6, B12 0.1 Micronutrients stock 0.8 The culture The medium is sterilized in 3 parts.
    [0024] Glucose is sterilized with KH2PO4 for addition just before To.
    [0025] The rest of the salts are sterilized in a fermenter with 0.75 ml / l of Clearol FBA 3107. The trace elements and vitamins are sterilized by filtration. The volume at To represents 75% of the final volume. The pH is adjusted to To by ammonia then it is regulated to 6 always with ammonia.
    [0026] Table 11 Culture medium% (w / w) KH 2 PO 4 0.80 (NH 4) 2 SO 4 0.33 Na 2 SO 4 0.67 NaCl 0.27 Ca Cl 2 (H 2 O) 0.03 Mg SO 4 (H 2 O) 1.00 Glucose anhydrous 6.00 Vitamins mother solution 81, 86, 812 0.20 Micronutrients mother solution 0.27 A batch Fed glucose (concentration: 500 g / 1) is continuously fed from constant rate To (to be adapted calculated) to not be at a concentration below 20 g / L. In the end, the glucose will be exhausted without falling below 5 g / L when the fermentation is stopped. The culture is conducted at 28 ° C and lasts from 70 to 85 hours with a fixed and constant OTR (oxygen uptake rate) of 20 to 30 mmol of O 2 / L / h. g / L elements MnCl2 2h20 8.60 CoCl2 6H20 0.2 NiSO4 6H20 7.50 Na2MoO4 2H20 0.15 ZnSO4 7H20 5.70 Cu So4 5h20 6.50 FeSO4 7 H2O 32.00 Zinc acetate 0.01 EDTA At pH> 3 vitamins g / L B1 45 B6 45 20 B12 0.25 25 Two fermentation conditions are used: As a control: so-called "standard" conditions, in which the C / N ratio (carbon consumed on consumed nitrogen) is maximized so as to produce essentially lipids by interrupting the supply of nitrogen but not that of the carbon substrate, this without limitation in 02. These conditions are therefore deficient in nitrogen. The removal of the nitrogen supply occurs when one or more salts are exhausted. The actual growth is then impossible or very limited: the cell multiplication rate drops in favor of the lipid enrichment of the cells present. The overall mass of the cells increases but the number of cells changes little because the growth rate falls. According to the invention: Conditions for producing DHA-rich lipids with amino acids rich in arginine and glutamic acid by limiting the rate of growth by limiting the transfer to O 2 so that pt drops to ii / pmax <0, 2 while maintaining the supply of glucose and nitrogen preferentially through the regulation of pH with ammonia.
    [0027] FIG. 1 shows the evolution of the proportion of arginine and glutamic acid among the amino acids as a function of the C / N calculated at the end of the culture. It appears that the process promotes the production of amino acids arginine and glutamic acid since the C / N ratio is less than 15 (# p / pmax <0.2). Table III below shows, for the CNCM 1-4702 strain, the fatty acid and amino acid composition of the biomass produced according to the "conventional" operating conditions and in accordance with the invention.
    [0028] Table III Conventional culture Use of the process of the invention Lipids on Biomass (g / g) 0.60 0.35 Proteins on Biomass according to N 6.25 (g / g) 0.12 0.53 DHA / Fatty acids (g / g) / g) 0.24 0.47 Aspartic acid on AAT (g / g) 0.12 0.05 Threonine on AAT (g / g) 0.06 0.03 Serine on AAT (g / g) 0 , 06 0.03 Glutamic acid on 1 AAT (g / g) 0.11 0.40 Glycine on AAT (g / g) 0.05 0.03 Alanine on AAT (g / g) 0.07 0, 04 Valine on AAT (g / g) 0.06 0.03 Isoleucine on AAT (g / g) 0.05 0.03 Leucine on AAT (g / g) 0.08 0.04 Tyrosine on AAT (g / g) 0.04 0.02 Phenylalanine on AAT (g / g) 0.04 0.03 Lysine on AAT (g / g) 0.07 0.04 Histidine on AAT (g / g) 0.02 0.01 Arginine on 1 AAT (g / g) 0.06 0.16 Proline on AAT (g / g) 0.05 0.03 Cystine on AAT (g / g) 0.02 0, 01 Methionine on AAT (g / g) 0.03 0.02 Tryptophan on AAT (g / g) 0.02 0.01 The proportion of glutamic acid on the sum of amino acids is multiplied by 3.75 and the proportion of arginine on the sum of the acids a mined is multiplied by 5 2.75. The lipid composition is reduced but the DHA content of the fatty acids is almost doubled. EXAMPLE 2 Cropping Conditions of the CNCM 1-4469 Strain The cultivation conditions of this microalgae are the same as those of Example 1 (with the exception of the rate of inoculum chosen in preculture, of the order of 5 g / I for Schizochytrium sp.). According to two culture conditions conducted in a "conventional" manner and according to the invention. Table IV below shows the fatty acid and amino acid composition of the biomass produced according to the "conventional" operating conditions and in accordance with the invention.
    [0029] Table IV Conventional culture Use of the process of the invention Lipids on Biomass (g / g) 0.46 0.26 Proteins on Biomass according to N 6.25 (g / g) 0.21 0.43 DHA / Fatty acids (g / g) / g) 0.42 0.52 Aspartic acid on AAT (g / g) 0.12 0.08 Threonine on AAT (g / g) 0.05 0.04 Serine on AAT (g / g) 0 , 05 0.04 Glutamic acid on 1 AAT (g / g) 0.15 0.26 Glycine on AAT (g / g) 0.05 0.05 Alanine on AAT (g / g) 0.08 0, 06 Valine on AAT (g / g) 0.06 0.05 Isoleucine on AAT (g / g) 0.04 0.03 Leucine on AAT (g / g) 0.08 0.06 Tyrosine on AAT (g / g) 0.04 0.03 Phenylalanine on AAT (g / g) 0.04 0.03 Lysine on AAT (g / g) 0.06 0.05 Histidine on AAT (g / g) 0.02 0.02 Arginine on 1 AAT (g / g) 0.06 0.10 Proline on AAT (g / g) 0.04 0.07 Cystine on AAT (g / g) 0.02 0, 01 Methionine on AAT (g / g) 0.02 0.02 Tryptophan on AAT (g / g) 0.02 0.01 For the strain Schizochytrium sp the effects are identical but of less amplitude. In addition, there is also a 75% increase in the proportion of proline among the amino acids. Amino acid arginine and glutamic acid levels increased by 60% and 75%, respectively, while the protein content doubled. DHA content in fatty acids increases by 23%. 10
    权利要求:
    Claims (8)
    [0001]
    CLAIMS 1-Process for enriching a biomass of microalgae of the genus Thraustochytrium in docosahexaenoic acid (DHA) and amino acids arginine and glutamic acid, characterized in that it comprises a step aimed at limiting the growth rate of the microalga all by maintaining or continuously introducing a source of nitrogen into the fermentation medium.
    [0002]
    2. Process according to claim 1, characterized in that the microalgae are of the genus Schizochytrium sp or Schizochytrium mangrovei.
    [0003]
    3. Method according to either of the preceding claims, characterized in that the microalgae are a strain selected from strains CNCM 1-4469 and CNCM 1-4702 deposited in the National Collection of Cultures Microorganisms 15 Institut Pasteur respectively on April 14, 2011 and November 22, 2012.
    [0004]
    4. Process according to any one of the preceding claims, characterized in that it comprises a step consisting in maintaining or adding a source of nitrogen in the fermentation medium as soon as the value of the ratio of Wumax growth rates of the microalgae. becomes less than 0.2.
    [0005]
    5. Process according to any one of the preceding claims, characterized in that the limitation of the growth rate of the microalga is obtained by the reduction or the depletion of the fermentation medium by micronutrients or by the limitation of the transfer to 02, preferably by limiting the transfer to 02.
    [0006]
    6. Process according to any one of the preceding claims, characterized in that it further comprises the harvesting of the biomass, optionally the preparation of an extract or cell lysate from this biomass, and then optionally the extraction of the biomass. a crude oil rich in DHA.
    [0007]
    7- Process according to any one of the preceding claims, characterized in that the biomass obtained comprises at least 45% of DHA by weight of total fatty acids. 35
    [0008]
    8- Process according to any one of the preceding claims, characterized in that the biomass obtained comprises at least 40% of proteins by weight of biomass (g / g) expressed in N.6,25, of which at least 10% is arginine and at least 25% glutamic acid by weight over total amino acids.
    类似技术:
    公开号 | 公开日 | 专利标题
    EP3074522B1|2020-04-29|Process for enrichment of microalgal biomass with carotenoids and with proteins
    EP3083973B1|2019-05-08|Dha enrichment process of the traustochytrium species microalgae
    EP2954072B1|2016-11-16|Biomass of the microalgae schizochytrium mangrovei and method for preparing same
    EP3250699B1|2018-11-28|Enrichment process of the thraustochytrium species microalgae biomass in dha and in arginine and glutamic acid
    EP3097201B1|2018-11-28|Microalgal biomass protein enrichment method
    WO2015150716A2|2015-10-08|Method for culturing microalgae of the aurantiochytrium genus in a culture medium without chloride and without sodium for the production of dha
    EP3414335B1|2020-03-25|Method for the protein enrichment of microalgal biomass
    FR3003874A1|2014-10-03|PROCESS FOR ENRICHING PROTEIN FROM BIOMASS OF MICROALGUES
    US10597630B2|2020-03-24|Method for culture of microalgae
    EP2723876A1|2014-04-30|Novel strains of microalgae of the isochrysis genus for producing epa and dha in a mixotrophic mode
    WO2017103421A9|2017-07-27|Method for enriching protists with lipids rich in polyunsaturated fatty acids, more particularly of the omega 3 class, and implementation of same for the production of said lipids
    NZ733432B2|2022-02-01|Process for enriching the biomass of microalgae of the schizochytrium genus with dha and with arg and glu amino acids
    FR3031986A1|2016-07-29|PROCESS FOR ENRICHING PROTEIN FROM BIOMASS OF MICROALGUES
    同族专利:
    公开号 | 公开日
    FR3031984B1|2019-05-24|
    AU2016211105A1|2017-07-20|
    EP3250699A1|2017-12-06|
    CN107208119A|2017-09-26|
    KR20170105022A|2017-09-18|
    US20180002657A1|2018-01-04|
    NZ733432A|2021-10-29|
    WO2016120558A1|2016-08-04|
    ES2718771T3|2019-07-04|
    LT3250699T|2019-03-12|
    AU2016211105B2|2019-07-18|
    JP2018508199A|2018-03-29|
    EP3250699B1|2018-11-28|
    CA2974598A1|2016-08-04|
    JP6715252B2|2020-07-01|
    CN107208119B|2021-03-30|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    WO2001054510A1|2000-01-28|2001-08-02|Omegatech, Inc.|Enhanced production of lipids containing polyenoic fatty acids by high density cultures of eukaryotic microbes in fermentors|
    FR3001736A1|2013-02-06|2014-08-08|Roquette Freres|BIOMASS OF MICROALGUE SCHIZOCHYTRIUM MANGROVEI AND METHOD FOR PREPARING THE SAME|
    WO2014154787A2|2013-03-29|2014-10-02|Roquette Freres|Microalgal biomass protein enrichment method|
    US5340742A|1988-09-07|1994-08-23|Omegatech Inc.|Process for growing thraustochytrium and schizochytrium using non-chloride salts to produce a microfloral biomass having omega-3-highly unsaturated fatty acids|
    CN102787140A|2011-05-20|2012-11-21|罗盖特兄弟公司|Method for preparing and extracting squalene by microalgae|
    CN102787074B|2011-05-20|2016-06-08|罗盖特兄弟公司|Produce the Microalgae new strain of squalene|GB201701014D0|2017-01-20|2017-03-08|Megatech Res Gmbh|Composition and method of production thereof|
    KR102299183B1|2017-08-10|2021-09-08|더 유니버시티 오브 브리티쉬 콜롬비아|Method for preparing lipid in microalgae using amino acid supplementation|
    KR102100650B1|2018-06-29|2020-04-16|씨제이제일제당 주식회사|Novel microalgal strain of Thraustochytrium genus, and producing polyunsaturated fatty acids using the same|
    法律状态:
    2016-02-01| PLFP| Fee payment|Year of fee payment: 2 |
    2016-07-29| PLSC| Publication of the preliminary search report|Effective date: 20160729 |
    2017-01-31| PLFP| Fee payment|Year of fee payment: 3 |
    2018-01-31| PLFP| Fee payment|Year of fee payment: 4 |
    2019-01-30| PLFP| Fee payment|Year of fee payment: 5 |
    2020-01-30| PLFP| Fee payment|Year of fee payment: 6 |
    2021-01-28| PLFP| Fee payment|Year of fee payment: 7 |
    2022-01-31| PLFP| Fee payment|Year of fee payment: 8 |
    优先权:
    申请号 | 申请日 | 专利标题
    FR1550598A|FR3031984B1|2015-01-27|2015-01-27|PROCESS FOR ENRICHING THE BIOMASS OF MICROALGUES OF THE GENUS TRAUSTOCHYTRIUM IN DHA AND IN AMINO ACIDS ARG AND GLU|
    FR1550598|2015-01-27|FR1550598A| FR3031984B1|2015-01-27|2015-01-27|PROCESS FOR ENRICHING THE BIOMASS OF MICROALGUES OF THE GENUS TRAUSTOCHYTRIUM IN DHA AND IN AMINO ACIDS ARG AND GLU|
    ES16705239T| ES2718771T3|2015-01-27|2016-01-26|Enrichment procedure of the microalgae biomass of the Traustochytrium genus in DHA and in Arg and Glu amino acids|
    EP16705239.8A| EP3250699B1|2015-01-27|2016-01-26|Enrichment process of the thraustochytrium species microalgae biomass in dha and in arginine and glutamic acid|
    CN201680007337.2A| CN107208119B|2015-01-27|2016-01-26|Method for enriching the biomass of microalgae of the genus thraustochytrium having DHA and having ARG and GLU amino acids|
    LTEP16705239.8T| LT3250699T|2015-01-27|2016-01-26|Enrichment process of the thraustochytrium species microalgae biomass in dha and in arginine and glutamic acid|
    NZ733432A| NZ733432B2|2015-01-27|2016-01-26|Process for enriching the biomass of microalgae of the schizochytrium genus with dha and with arg and glu amino acids|
    AU2016211105A| AU2016211105B2|2015-01-27|2016-01-26|Process for enriching the biomass of microalgae of the Thraustochytrium genus with DHA and with arg and glu amino acids|
    CA2974598A| CA2974598A1|2015-01-27|2016-01-26|Process for enriching the biomass of thraustochytrium genus microalgae with dha and with arg and glu amino acids|
    KR1020177020909A| KR20170105022A|2015-01-27|2016-01-26|Method of concentration of microalgae biomass of Traus tritium with DHA and ARG and GLU amino acids|
    PCT/FR2016/050159| WO2016120558A1|2015-01-27|2016-01-26|Process for enriching the biomass of microalgae of the thraustochytrium genus with dha and with arg and glu amino acids|
    JP2017539445A| JP6715252B2|2015-01-27|2016-01-26|Process for enriching the biomass of a microalgae of the genus Thraustochytrium with DHA and with the amino acids ARG and GLU|
    US15/546,606| US20180002657A1|2015-01-27|2016-01-26|Process for enriching the biomass of microalgae of the thraustochytrium genus with dha and with arg and glu amino acids|
    [返回顶部]